Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Medical Oncology · Anal Cancer

Understanding Your Anal Cancer Diagnosis

At a Glance

For most localized anal cancers, especially the common type linked to HPV, combined chemotherapy and radiation is the usual treatment. It aims to cure the cancer while preserving the muscles that control bowel movements, but recovery and treatment response can take months and may require long-term support.

Receiving a diagnosis of anal cancer can feel overwhelming, not only because of the medical complexity but also due to the sensitive nature of the location. It is important to know that you are not alone, and this diagnosis is not a reflection of your choices or character. Most people diagnosed with this condition have many questions about what this means for their future and how their life will change.

Understanding Anal Cancer and HPV

One of the most important things to understand is that approximately 90% of squamous cell carcinomas (the most common type of anal cancer) are linked to the human papillomavirus (HPV) [1]. HPV is a very common virus that most adults will encounter at some point in their lives. In many cases, the virus was acquired decades before a cancer diagnosis and remained “silent” in the body for years; testing cannot determine when or from whom an infection was acquired.

Because of the connection to HPV and the anatomical site, some patients feel a sense of stigma, shame, or embarrassment [1]. These feelings are common but medically unwarranted. A cancer diagnosis is a health event, not a moral failing. Framing this as a medical condition—just like any other cancer—can help you focus on the path forward. Early support from a counselor or specialist can help manage the fear and distress that often accompany this diagnosis [2].

How Anal Cancer Differs from Rectal Cancer

It is a common mistake to group anal cancer with colon or rectal cancers, but for localized disease without distant spread, they are fundamentally different diseases:

  • Origin: Most anal cancers are squamous cell carcinomas, meaning they start in the skin-like cells of the anal canal [3]. In contrast, rectal cancers are typically adenocarcinomas, which start in the mucus-producing glands of the rectum [4].
  • Treatment Philosophy: In rectal cancer, neoadjuvant therapy followed by surgery is often a primary part of the initial treatment plan [5]. In localized anal squamous cell carcinoma, the gold standard is chemoradiation—a combination of chemotherapy and radiation [6].
  • Sphincter Preservation: The primary goal of treating localized anal cancer is to cure the disease while keeping the anal sphincter (the muscles that control bowel movements) anatomically intact [5]. This approach allows many patients to avoid a permanent colostomy (an opening in the belly for waste), though it does not guarantee normal bowel continence [7]. Surgery is typically reserved for cases where the cancer does not fully respond to chemoradiation or if it returns later [8]. (Note: Anal adenocarcinoma and metastatic disease follow different protocols, often more similar to rectal cancer).

Why Specialist Care Matters

Anal cancer is rare, with an incidence rate of approximately 1.9 per 100,000 people in the United States [9]. Because it is uncommon, many general oncologists may only see a few cases in their entire career.

It is highly advisable to seek specialist multidisciplinary review [10]. This involves teams of specialists—including medical oncologists, radiation oncologists, and colorectal surgeons—who work together to create a precise plan. Research shows that completing the full course of treatment without unnecessary long interruptions is vital for the best possible outcome [7]. Treatment can sometimes be coordinated locally with expert consultation, so travel is not always mandatory, but expert input is vital.

Treatment Goals and Long-Term Health

The standard treatment for localized anal cancer is a combination of radiation and chemotherapy (often using medications called Mitomycin and 5-FU or Capecitabine) [11][12].

While this treatment is highly effective at curing the cancer, it can cause long-term side effects that impact your quality of life. Research is ongoing to better manage these challenges, which can include:

  • Bowel Changes: Some survivors experience increased urgency, diarrhea, or difficulty with bowel control [13][14].
  • Sexual Health and Fertility: Both men and women may experience changes in sexual function or comfort following radiation [15][16]. Pelvic radiation can also cause permanent reproductive changes, so fertility preservation should be discussed before treatment begins.
  • Pelvic Health: Urinary issues or pelvic floor weakness can occur months or years after treatment [15][17].

It is important to remember that your medical team can help manage these issues through pelvic floor physical therapy, specialized counseling, and other supportive care measures [18][19]. After treatment ends, your doctors will monitor you closely using physical exams and imaging. Response to treatment can be slow, sometimes taking up to six months to show full results [20][21].

Common questions in this guide

What treatment is usually used first for localized anal cancer?
For most localized anal squamous cell cancers, the usual first treatment is chemoradiation: radiation given with chemotherapy such as mitomycin plus 5-FU or capecitabine. This approach aims to cure the cancer while preserving the anal sphincter. Surgery is generally considered if cancer remains after treatment or comes back.
How is anal cancer different from rectal cancer?
Most anal cancers are squamous cell cancers that begin in skin-like cells of the anal canal, while most rectal cancers are gland-forming adenocarcinomas. Because they are different diseases, localized anal cancer is commonly treated with chemoradiation, whereas rectal cancer often follows a different plan that may include surgery. Anal adenocarcinoma and cancer that has spread can require other approaches.
Does HPV cause anal cancer, and does it mean I did something wrong?
About 90% of anal squamous cell carcinomas are linked to HPV, a very common virus. HPV may have been acquired many years before cancer was found, and testing cannot show when or from whom it came. An HPV-related cancer is a medical condition, not a sign of blame or a moral failing.
Will I need a permanent colostomy after anal cancer treatment?
For localized anal squamous cell cancer, treatment is designed to preserve the anal sphincter, so many people can avoid a permanent colostomy. However, preserving the muscles does not guarantee normal bowel control, and surgery may be needed if chemoradiation does not fully work or the cancer returns. Your stage and treatment response are important factors.
Why should I see a multidisciplinary anal cancer team?
Anal cancer is uncommon, so a team that includes medical oncology, radiation oncology, and colorectal surgery can provide coordinated expertise. The team can help plan treatment, reduce avoidable interruptions, and monitor recovery. Treatment may sometimes be delivered close to home with guidance from specialists.
What long-term problems can happen after anal cancer treatment?
Some people develop bowel urgency, diarrhea, or difficulty controlling bowel movements after treatment. Radiation can also affect sexual function, fertility, urinary health, and pelvic-floor strength. Pelvic-floor physical therapy, counseling, and other supportive care can help, and fertility concerns should be discussed before treatment.
How long does it take to know whether chemoradiation worked?
The cancer may continue to shrink after chemoradiation, and a complete response can take up to six months. Doctors use physical examinations and imaging over time rather than judging the final result immediately after treatment. Ask your team what follow-up schedule fits your stage and response.

Get notified when new evidence is published on anus cancer.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (21)
  1. 1

    Understanding Disclosure Decisions and Communication About HPV-Related Cancer: A Qualitative Exploration of Stigma and Social Support.

    Villalona S, Sanchez J, Mangkalard P, Best AL

    Healthcare (Basel, Switzerland) 2025; (13(9)) doi:10.3390/healthcare13090966.

    PMID: 40361744
  2. 2

    Emotional Distress Prior to Chemoradiation for Rectal or Anal Cancer.

    Rades D, Al-Salool A, Yu NY, Bartscht T

    In vivo (Athens, Greece) 2023; (37(3)):1205-1210 doi:10.21873/invivo.13197.

    PMID: 37103088
  3. 3

    A case of a rare type of cancer: Anal squamous cell carcinoma in a patient without significant risk factors.

    English K, Erpelding M, Kaldas S, Semoin S

    Qatar medical journal 2024; (2024(1)):7 doi:10.5339/qmj.2024.7.

    PMID: 38362253
  4. 4

    An Updated Review on Imaging and Staging of Anal Cancer-Not Just Rectal Cancer.

    Congedo A, Mallardi D, Danti G, et al.

    Tomography (Ann Arbor, Mich.) 2023; (9(5)):1694-1710 doi:10.3390/tomography9050135.

    PMID: 37736988
  5. 5

    Surgical Options in the Treatment of Lower Gastrointestinal Tract Cancers.

    Porpiglia AS, Sigurdson ER

    Current treatment options in oncology 2015; (16(9)):46 doi:10.1007/s11864-015-0363-3.

    PMID: 26188639
  6. 6

    State of the art treatment for stage I to III anal squamous cell carcinoma: A systematic review and meta-analysis.

    Werner RN, Gaskins M, Avila Valle G, et al.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2021; (157()):188-196 doi:10.1016/j.radonc.2021.01.031.

    PMID: 33549645
  7. 7

    Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma: Use, Risk Factors, and Outcomes in a Canadian Population.

    Patel SV, Ko G, Raphael MJ, et al.

    Diseases of the colon and rectum 2020; (63(6)):748-757 doi:10.1097/DCR.0000000000001630.

    PMID: 32384405
  8. 8

    Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.

    Benson AB, Venook AP, Al-Hawary MM, et al.

    Journal of the National Comprehensive Cancer Network : JNCCN 2023; (21(6)):653-677 doi:10.6004/jnccn.2023.0030.

    PMID: 37308125
  9. 9

    HIV-Associated Anal Cancer.

    Khandwala P, Singhal S, Desai D, et al.

    Cureus 2021; (13(5)):e14834 doi:10.7759/cureus.14834.

    PMID: 34104584
  10. 10

    How I treat anal squamous cell carcinoma.

    Martini G, Arrichiello G, Borrelli C, et al.

    ESMO open 2020; (4(Suppl 2)):e000711 doi:10.1136/esmoopen-2020-000711.

    PMID: 32883674
  11. 11

    Radiation Therapy for Anal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline.

    Feng M, Hallemeier CL, Almada C, et al.

    Practical radiation oncology 2025; (15(4)):367-386 doi:10.1016/j.prro.2025.02.001.

    PMID: 40023252
  12. 12

    Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma: ASCO Guideline.

    Morris VK, Kennedy EB, Amin MA, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2025; (43(5)):605-615 doi:10.1200/JCO-24-02120.

    PMID: 39680825
  13. 13

    Late gastrointestinal toxicity after radiotherapy for anal cancer: a systematic literature review.

    Pan YB, Maeda Y, Wilson A, et al.

    Acta oncologica (Stockholm, Sweden) 2018; (57(11)):1427-1437 doi:10.1080/0284186X.2018.1503713.

    PMID: 30264638
  14. 14

    Late effects and quality of life after chemo-radiation for the treatment of anal cancer.

    Knowles G, Haigh R, McLean C, Phillips H

    European journal of oncology nursing : the official journal of European Oncology Nursing Society 2015; (19(5)):479-85.

    PMID: 25911268
  15. 15

    Management of late adverse effects after chemoradiation for anal cancer.

    Haas S, Mikkelsen AH, Kronborg C, et al.

    Acta oncologica (Stockholm, Sweden) 2021; (60(12)):1688-1701 doi:10.1080/0284186X.2021.1983208.

    PMID: 34845967
  16. 16

    Vaginal and sexual health after radiotherapy for anal cancer: A Danish prospective cohort study.

    Steffensen JH, Serup-Hansen E, Jakobsen AV, et al.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2026; (219()):111496 doi:10.1016/j.radonc.2026.111496.

    PMID: 41903610
  17. 17

    Long-Term Patient-Reported Quality of Life of Anal Cancer Survivors Treated With Intensity Modulated Radiation Therapy and Concurrent Chemotherapy: Results From a Prospective Phase II Trial.

    Joseph K, Balushi MA, Ghosh S, et al.

    International journal of radiation oncology, biology, physics 2023; (117(2)):434-445 doi:10.1016/j.ijrobp.2023.04.023.

    PMID: 37148982
  18. 18

    Patients' perspective in anal cancer.

    Manfrida S, Dinapoli L, De Luca V, et al.

    ESMO gastrointestinal oncology 2026; (13(Pt A)):100203 doi:10.1016/j.esmogo.2025.100203.

    PMID: 42582940
  19. 19

    A multi-disciplinary model of survivorship care following definitive chemoradiation for anal cancer.

    Savoie MB, Laffan A, Brickman C, et al.

    BMC cancer 2019; (19(1)):906 doi:10.1186/s12885-019-6053-y.

    PMID: 31510960
  20. 20

    Current treatment and future directions in the management of anal cancer.

    Tchelebi LT, Eng C, Messick CA, et al.

    CA: a cancer journal for clinicians 2022; (72(2)):183-195 doi:10.3322/caac.21712.

    PMID: 34847242
  21. 21

    Trends in primary surgery and overall survival in non-metastatic anal cancer: a population-based analysis.

    Shen C, Conces M, Ciombor K, et al.

    The oncologist 2026; (31(6)) doi:10.1093/oncolo/oyag148.

    PMID: 42001213

This page provides general information about anal cancer diagnosis, treatment, and follow-up; it is for informational purposes only and does not constitute medical advice. Your oncology team should interpret your stage, treatment options, fertility concerns, and side effects.

Guide contents anus cancer
Research & Literature
02 Symptoms and the Risk of Misdiagnosis